Cassava Sciences

company

About

Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.70M
Industries
Biopharma,Biotechnology,Life Science,Medical,Neuroscience,Pharmaceutical
Founded date
Jan 1, 1998
Number Of Employee
11 - 50
Operating Status
Active

Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience. We translate novel scientific insights into new medicines. That’s a drastic challenge. Our work is complex, risky, labor-intensive, persistent and expensive.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$6.90M
Cassava Sciences has raised a total of $6.90M in funding over 2 rounds. Their latest funding was raised on May 12, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 12, 2021 Grant $2.70M 1 National Institutes of Health Detail
Apr 23, 2020 Grant $2.50M 1 National Institutes of Health Detail
Sep 21, 2015 Grant $1.70M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Cassava Sciences is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant